Cited by 14HIV Research and TreatmentSARS-CoV-2 and COVID-19 ResearchInfluenza Virus Research Studies

Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

Open access
del Moral-Sánchez, Iván, Wee, Edmund G., Xian, Yuejiao, Lee, Wen-Hsin, Allen, Joel D., Torrents de la Peña, Alba, Fróes Rocha, Rebeca, Ferguson, James +18 more·2024·npj Vaccines

Published version of a preprint

Abstract

Recombinant native-like HIV-1 envelope glycoprotein (Env) trimers are used in candidate vaccines aimed at inducing broadly neutralizing antibodies. While state-of-the-art SOSIP or single-chain Env designs can be expressed as native-like trimers, undesired monomers, dimers and malformed trimers that elicit non-neutralizing antibodies are also formed, implying that these designs could benefit from further modifications for gene-based vaccination approaches. Here, we describe the triple tandem trimer (TTT) design, in which three Env protomers are genetically linked in a single open reading frame and express as native-like trimers. Viral vectored Env TTT induced similar neutralization titers but with a higher proportion of trimer-specific responses. The TTT design was also applied to generate influenza hemagglutinin (HA) trimers without the need for trimerization domains. Additionally, we used TTT to generate well-folded chimeric Env and HA trimers that harbor protomers from three different strains. In summary, the TTT design is a useful platform for the design of HIV-1 Env and influenza HA immunogens for a multitude of vaccination strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41541-024-00862-8

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
del Moral-Sánchez, I., Wee, E. G., Xian, Y., Lee, W.-H., Allen, J. D., Torrents de la Peña, A., Fróes Rocha, R., Ferguson, J., León, A. N., Koekkoek, S., Schermer, E. E., Burger, J. A., Kumar, S., Zwolsman, R., Brinkkemper, M., Aartse, A., Eggink, D., Han, J., Yuan, M., Crispin, M., Ozorowski, G., Ward, A. B., Wilson, I. A., Hanke, T., Sliepen, K., & Sanders, R. W.
Affiliations
  • University of Oxford (GB)
  • Scripps Research Institute (US)
  • University of Southampton (GB)
  • Amsterdam University Medical Centers (NL)
  • Biomedical Primate Research Centre (NL)
  • Cornell University (US)
Corresponding author
Sanders, Rogier W.
Venue
npj Vaccines
Published
2024-04-06
Volume
9
Issue
1
Pages
74-74
ISSN
2059-0105 (ISSN-L)
OpenAlex
W4394014785
Cited by
14
References
7
Citations by year
2026: 3 · 2025: 9 · 2024: 2
FWCI
3.20
Type
journal article
Language
en
Open access
Locations
  • npj Vaccines (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion, cc-by)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Bill and Melinda Gates Foundation (OPP1111923, OPP1115782)
  • Aids Fonds (2016019)
  • European Molecular Biology Organization (STS-7814)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Keywords
HIV-1 envelope glycoprotein, influenza hemagglutinin, nucleic acid-based vaccines, broadly neutralizing antibodies, SOSIP trimers, viral vector vaccines, trimerization domain, immunogen design

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review